Next-generation cloud-native solution accelerates sustainable therapeutic production and cuts R&D timelines in half.
Seoul, South Korea — June 29, 2025 —
SyntecBio, a pioneer in AI-driven biotechnology, today announced the commercial launch of its AI-Powered Biomanufacturing Platform. This fully cloud-native system leverages machine learning and advanced automation to streamline strain engineering, optimize fermentation processes, and reduce biologics development timelines by up to 50%.
Key Features & Benefits
Automated Strain Design
Machine-learning algorithms predict optimal genetic edits to boost target yield, reducing trial-and-error by 60%.
Real-Time Process Analytics
Integrated sensors and an interactive dashboard monitor biomass concentrations, metabolite levels, and critical quality attributes live.
Eco-Efficient Fermentation
Dynamic control loops adjust pH, temperature, and nutrient feed in real time—cutting energy and water usage by up to 30%.
Seamless LIMS/ERP Integration
Out-of-the-box connectors enable rapid data exchange with leading lab information management and enterprise resource systems.
Regulatory-Ready Traceability
End-to-end audit trails and batch records simplify compliance with FDA, EMA, and global biomanufacturing standards.
Executive Quote
“With our AI-Powered Biomanufacturing Platform, we’re not just automating workflows—we’re redefining what’s possible in biologics R&D,” said Dr. Jane Lee, Chief Executive Officer of SyntecBio. “Customers can now go from gene construct to GMP-ready batch in weeks instead of months, accelerating the delivery of life-saving therapies.”
Early Adopters & Use Cases
Biotech Startups
Rapidly prototype novel enzymes for industrial biocatalysis.
Pharmaceutical Partners
De-risk scale-up of monoclonal antibody and vaccine programs.
Academic Collaborations
Accelerate proof-of-concept studies in synthetic vaccine and cell-therapy research.
To schedule a live demo or learn more about SyntecBio’s AI-Powered Biomanufacturing Platform, visit syntecbiofuel.com
About SyntecBio
SyntecBio is a Seoul-based innovator in AI-driven biomanufacturing. Founded in 2018, its mission is to harness machine learning and synthetic biology to make therapeutics more accessible, sustainable, and cost-effective. For more information, visit www.syntecbio.com.
Media Contact
Lee Min-joon
Director, Global Communications, SyntecBio
